Dr Pamela Mccall
- Research Assistant (Experimental Therapeutics)
telephone: 01412111933
email: Pamela.McCall@glasgow.ac.uk
2011
McCall, P,, Catlow, J., McArdle, P.A., McMillan, D.C. , and Edwards, J. (2011) Tumoral C-reactive protein and nuclear factor kappa-B expression are associated with clinical outcome in patients with prostate cancer. Cancer Biomarkers, 10 (2). pp. 91-99. ISSN 1574-0153 (doi:10.3233/CBM-2012-0236)
Mukherjee, R., McGuinness, D.H. , McCall, P. , Underwood, M A, Seywright, M, Orange, C, and Edwards, J. (2011) Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer. British Journal of Cancer, 104 (12). pp. 1920-1928. ISSN 0007-0920 (doi:10.1038/bjc.2011.163)
2010
Teo, K., McVitty, C., Mitchell, T., McCall, P. , and Edwards, J. (2010) Cyclin D1 expression influences overall survival in androgen independent prostate cancer. British Journal of Cancer, 97 (S6). p. 26. ISSN 0007-0920 (doi:10.1002/bjs.7351)
2009
McCall, P., McKenzie, L., Lim, Y.R., Sewright, M., Orange, C., and Edwards, J. (2009) The role of Androgen receptor phosphorylation at three different serine phosphorylation sites in the development of hormone refractory prostate cancer. European Urology Supplements, 8 (4). p. 247. ISSN 1569-9056 (doi:10.1016/S1569-9056(09)60502-9)
2008
McCall, P., Gemmell, L.K., Mukherjee, R., Bartlett, J.M.S., and Edwards, J. (2008) Phosphorylation of the androgen receptor is associated with reduced survival in hormonerefractory prostate cancer patients. British Journal of Cancer, 98 (6). pp. 1094-1101. ISSN 0007-0920 (doi:10.1038/sj.bjc.6604152)
McCall, P., Witton, C.J., Grimsley, S., Nielsen, K.V., and Edwards, J. (2008) Is PTEN loss associated with clinical outcome measures in human prostate cancer? British Journal of Cancer, 99 (8). pp. 1296-1301. ISSN 0007-0920 (doi:10.1038/sj.bjc.6604680)
Traynor, P., McGlynn, L.M. , Mukherjee, R., Grimsley, S.L.S., Bartlett, J.M.S., and Edwards, J. (2008) An increase in N-Ras expression is associated with development of hormone refractory prostate cancer in a subset of patients. Disease Markers, 24 (3). pp. 157-165. ISSN 0278-0240
2007
Tam, L., McGlynn, L.M. , Traynor, P. , Mukherjee, R., Bartlett, J.M.S., and Edwards, J. (2007) Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer. British Journal of Cancer, 97 (3). pp. 378-383. ISSN 0007-0920 (doi:10.1038/sj.bjc.6603871)
Teo, K., Gemmell, L., Mukherjee, R., Traynor, P. , and Edwards, J. (2007) Bad expression influences time to androgen escape in prostate cancer. BJU International, 100 (3). pp. 691-696. ISSN 1464-4096 (doi:10.1111/j.1464-410X.2007.07001.x)
2006
Edwards, J., Traynor, P. , Munro, A. , Pirrett, C.F., Dunne , B., and Bartlett, J.M.S. (2006) The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer. Clinical Cancer Research, 12 (1). pp. 123-130. ISSN 1078-0432 (doi:10.1158/1078-0432.CCR-05-1445)
